Skip to main content

Table 2 Drugs and their concentrations used with cardiomyocytes derived from human embryonic and induced pluripotent stem cells

From: Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes

Drug

Concentrations

Isoprenaline

nM: 81, 402

Cisapride monohydrate

nM: 40, 83, 120, 165, 330

Erythromycin

µM: 1.5, 3, 5.5, 8, 16

Sotalol

µM: 0.8, 1.6, 5.7, 9.7, 19.4

Quinidine

µM: 1.5, 3, 9, 15, 30

E-4031

nM: 10, 100, 300, 500, 700